A detailed history of Stephens Inc transactions in Viatris Inc stock. As of the latest transaction made, Stephens Inc holds 34,452 shares of VTRS stock, worth $365,535. This represents 0.01% of its overall portfolio holdings.

Number of Shares
34,452
Previous 39,254 12.23%
Holding current value
$365,535
Previous $425,000 3.29%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $54,118 - $64,971
-4,802 Reduced 12.23%
34,452 $411,000
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $8,682 - $10,741
990 Added 2.59%
39,254 $425,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $9,599 - $11,361
-1,001 Reduced 2.55%
38,264 $377,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $18,716 - $21,351
-2,075 Reduced 5.02%
39,265 $391,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $7,424 - $9,893
-807 Reduced 1.91%
41,340 $397,000
Q4 2022

Jan 25, 2023

SELL
$8.72 - $11.56 $60,324 - $79,972
-6,918 Reduced 14.1%
42,147 $469,000
Q3 2022

Nov 02, 2022

BUY
$8.48 - $11.13 $1,407 - $1,847
166 Added 0.34%
49,065 $418,000
Q2 2022

Aug 03, 2022

BUY
$9.95 - $12.27 $3,542 - $4,368
356 Added 0.73%
48,899 $512,000
Q1 2022

May 04, 2022

BUY
$9.81 - $15.4 $14,960 - $23,485
1,525 Added 3.24%
48,543 $528,000
Q4 2021

Mar 07, 2022

SELL
$12.09 - $14.68 $115,652 - $140,428
-9,566 Reduced 16.91%
47,018 $636,000
Q3 2021

Oct 27, 2021

SELL
$13.25 - $15.13 $266,126 - $303,886
-20,085 Reduced 26.2%
56,584 $767,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $7,769 - $9,673
-599 Reduced 0.78%
76,669 $1.1 Million
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $24,040 - $32,797
1,769 Added 2.34%
77,268 $1.08 Million
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $1.08 Million - $1.41 Million
75,499 New
75,499 $1.42 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.